Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
14.33%
↑ 138% vs avg
Percentile
P93
Near historical high
Streak
3 yr
Consecutive growthAccelerating
Average
-37.97%
Historical baseline
PeriodValue
202514.33%
20242.44%
2023-23.59%
2022-28.44%
2021-11.12%
2020-29.11%
2019-56.93%
2018-28.64%
2017-140.94%
2016-77.73%